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Introduction: Coronavirus Disease 2019 (COVID-19) results from Severe Acute Respiratory 
Syndrome Coronavirus 2 (SARS-CoV-2). it is now a pandemic that affects us all. For patients 
referring to the addiction care systems, this pandemic can create additional vulnerabilities. A 
great deal of effort has made to re-organize the care systems for patients with addiction.  Our 
study focuses on the voice of our patients, on clues to adapt treatment, and on the impact of the 
pandemic on the therapeutic alliance. 
Methods: A qualitative design was used to develop a description and understanding of general 
and clinically relevant aspects of the impact of the COVID-19 pandemic.  Fifteen addicted 
patients (11 under treatment and 4 in recovery) were interviewed by 4 interviewers according 
to the COREQ (consolidated criteria for reporting qualitative research). 
Results: COVID-19 has had a serious impact on thoughts, feelings, and behaviors. 
Interviewees shared their anxieties about their health and the health of their relatives. 
Frightening thoughts were associated with a range of negative feelings and behaviors, such as 
stress, anger, avoidance, and isolation. The use of psychoactive substances differed between 
the patients in treatment with those who are in stable recovery. In the former, all succeeded in 
staying abstinent. They have experienced that solidarity and connectedness were essential in 
sustaining their recovery. Those still in treatment were fighting against the temptation to start 
using again; they felt emotionally isolated and sometimes patronized by health care workers.
Conclusion: The elaboration of the interviewees on the therapeutic relationship provides 
promising clues to optimize that relationship.  Remembering this common expression, “we 
are all in this together,” shared decision making could very well be used to shape effective and 
receptive treatment interventions during the different challenges faced at different stages of the 
COVID-19 epidemic. 
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1. Introduction
oronavirus Disease 2019 (COVID-19) re-
sults from Severe Acute Respiratory Syn-
drome Coronavirus 2 (SARS-CoV-2). It is 
now a pandemic that affects everybody with 
grave implications during the acute stage of 
the burden imposed on healthcare systems in all coun-
tries. Guidelines on how healthcare systems respond to 
the COVID-19 epidemic was initially formulated by the 
WHO (The World Health Organization, 2020) and fol-
lowed up by several national and regional contingency 
or continuity plans to divert non-essential services (espe-
cially around chronic non-communicable care delivery) 
to COVID19 intensive care units.  This has also deployed 
a substantial amount of the workforce to unfamiliar en-
vironments.  Besides, this workforce had to be trained, 
repurposed, and mobilized according to these rapidly de-
signed essential services.
It is encouraging to note that a great deal of effort has 
also been put into the re-organization of the health care 
systems for patients with addiction disorders. In most 
countries, this service was deemed as an essential service 
that should be delivering before COVID19 care during 
this epidemic. To optimize health care services for our 
patients, researchers have issued numerous proposals 
(Farhoudian et al., 2020; Marsden et al., 2020) with de-
tailed guidelines on contingencies to support continuity 
of service in both drug and alcohol users. 
In general, as a reaction to an infectious disease out-
break like COVID19, there is a rapid increase in adverse 
psychological responses in the general population. They 
are reacting to this event with disbelief and confusion 
due to inadequate information, lack of insight, and poor 
communication by their authorities on how this will be 
resolved (Wang et al., 2020). According to this study, 
respondents rated the psychological impact of the out-
Highlights 
● COVID-19 influenced the lives of addicted patients in a way that is comparable with how we are all affected all by 
the pandemic.
●Because of the mostly negative thoughts, feelings and behavior the interviewees in treatment were vulnerable to 
relapse.
● Thoughts, feelings and behavior forms a good basis for a behavioral therapeutic intervention by making a func-
tional analysis and challenging irrational thoughts and looking together for more rational thoughts that can reduce 
negative feelings.
● Therapy has changed by necessary rules to mitigate COVID-19 spread, and patient and health care worker both are 
troubled by it. Just as Shared Decision Making helps to start a treatment, improves the working alliance, the adherence 
and the efficacy, this method could very well be used to shape effective and receptive treatment interventions during 
the different challenges faced at different stages of the COVID-19 epidemic. 
Plain Language Summary 
On several occasions it was suggested that it would be good to make addicted patients' voices heard in this COVID-19 
pandemic. Anecdotes are not suitable for this, so we conducted in the second week of April a qualitative study. We were 
able to develop a description and understanding of general and clinically relevant aspects of the impact of pandemic. 
Interviewees shared anxieties about their health and the health of their relatives. Frightening thoughts were associated 
with a range of negative feelings and behaviors such as stress, anger, avoidance and isolation. The use of psychoactive 
substances differed between the patients in treatment with those who are in stable recovery. In the former all succeeded 
in staying abstinent. They have experienced that solidarity and connectedness were essential in sustaining their re-
covery. Those still in treatment were fighting against the temptation to start using again, they felt emotionally isolated 
and sometimes patronized by health care workers. The elaboration of the interviewees on the therapeutic relationship 
provides promising clues to optimize that relationship. "We are all in it together!" Shared Decision Making could very 
well be used to shape effective and receptive treatment interventions during the different challenges faced at different 
stages of the COVID-19 epidemic. 
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break as moderate or severe. In particular, 16.5% of 
them reported moderate to severe depressive symptoms; 
28.8% moderate to severe anxiety symptoms; and 8.1% 
moderate to severe stress levels. Most of them were wor-
ried about their family members contracting COVID-19 
(75.2%)  (Wang et al., 2020). 
Soon, tools have become available to deal with these 
psychological consequences during the acute phase 
but not during protracted episodes (Centers for Disease 
Control and Prevention, 2020). Additionally, there is an 
emerging number of (a) recovering and recovered CO-
VID19 individuals (Lee et al., 2007) and (b) healthcare 
intensivists and other health care workers (Tan et al., 
2020) who are or will be experiencing Post-Traumatic 
Stress Disorder (PTSD) like symptoms as this period 
progresses even further from weeks to months and per-
haps years. In the mean-time, there are rapidly emerging 
help centers to support individuals with mental health-
related problems (Center for Addiction and Mental 
Health, 2020) but again they have been erected for the 
acute phase of this global epidemic (Center for Addic-
tion and Mental Health, 2020).
For the patients who use mental health and addiction 
care systems, this pandemic can create additional vul-
nerabilities on their physical and psychological health 
(Volkow, 2020). Additionally, chronic, potentially life-
threatening, and stressful events increase the risk of re-
lapse (McCabe, Cranford, & Boyd, 2016). 
While mental health care workers will not be on the 
frontline confronting and treating acute COVID-19 dis-
ease, they may experience the same emotional responses 
as everyone else in the general population and perhaps 
even more. If that is the case, one can imagine the possi-
bility that a vulnerable patient would be meeting an anx-
ious, depressed, or stressed mental health care worker 
during this pandemic. It is pertinent therefore to take 
on the learning points from experience on the therapeu-
tic relationships during the prolonged crisis from other 
traumatic events such as conflicts and natural disasters 
(Baum, 2010), as treatment could be compromised be-
cause of the personal and professional impact of these 
traumatic events on health care workers (Tosone, Mc-
Tighe, & Bauwens, 2015). Guidelines for dealing with 
these situations were initiated and considered as help-
ful (American Psychological Association, 2001) in the 
future. 
Although it is too early to study the full psychological 
impact of the COVID-19 global epidemic on dyads of 
patients and health care workers within the mental health 
and addiction treatment systems, it is important to start 
asking patients about how they perceive the therapeutic 
relationship impacted on their lives for now. 
Listening to the voice of the patients who use our 
mental health and addiction care systems is important 
not only to understand better their concerns but it also 
provides unique and helpful insight on one of the cor-
nerstones of treatment, namely the therapeutic working 
alliance (Cook, Heather, & McCambridge, 2015). The 
purpose of this small qualitative person-centered study 
was to explore further the above issues.
Our exploration has three aims. Firstly, we want to lis-
ten to the voice of our patients. In other words, what 
they say about how the pandemic affects them. The 
second aim was to find clues in the answers of the pa-
tients that could be used to adapt a treatment that uses 
the principles of Cognitive Behavioral Therapy (CBT) 
to support a therapeutic intervention that allays the fears 
and anxieties expressed by the patients during this global 
pandemic. Finally the last aim was to explore the impact 
of this pandemic on their therapeutic relationship with 
their health care workers.
2.  Methods
2.1. Study Design 
We conducted a qualitative exploration following a 
phenomenological approach to develop a description and 
understanding of general and clinically relevant aspects 
of the impact of the COVID-19 pandemic in addicted 
patients. We used the consolidated criteria for reporting 
qualitative research (COREQ) to ensure the quality of 
the process, including aspects of the team, study meth-
ods, findings, analysis and interpretations (Tong, Sains-
bury, & Craig, 2007) (The COREQ checklist of this 
study is attached as supplementary material). We wanted 
to interview respondents as much as is needed to achieve 
saturation. There is no rule of thumb for the number of 
respondents to be included in a naturalistic exploration 
as we planned to perform. Therefore we used a constant 
comparative method (Bowen, 2008), meaning that it was 
checked by the first author with every new interview if 
new themes emerge. 
2.2. Study setting 
The study population consisted of patients with Sub-
stance Use Disorder (SUD) under treatment (n=11) and 
in recovery (n=4) in the southeastern part of the Neth-
erlands. This region was affected early during the pan-
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demic, in March 2020, and up to now (May 4, 2020) 
it has experienced the highest prevalence of COVID19 
infected people (8404 out of a total of 40571; 2.0,7%), 
hospitalized (2596 out of a total of 10995; 23.6%)  and 
deaths (1392 out of a total of 5056; 27.5%).  
2.3. Selection of participants 
We included 11 participants from our clinical practice 
(CDJ, JGDJV, and RP; n=9) or non-clinical projects 
(CV; n=2). RP and CV knew the four interviewees in 
stable recovery from their circle of acquaintances. None 
of us was the patients’ health care professional directly 
responsible for their treatment plans. 
2.4. Study Procedure
Before the interview, we asked the participants to an-
swer a few questions regarding their demographics and 
clinical features such as gender, age, psychiatric and 
addiction history, and treatment setting. Regarding CO-
VID-19, we asked them if they had presented with COV-
ID-19 symptoms, if anyone in their immediate area had 
been sick, and if someone had died from the infection. 
We developed a semi-structured interview with five rel-
evant sets of open questions relating to key topics of im-
pact (thoughts, feelings, and behavior) of the COVID-19 
pandemic (Table 1). The first two sets of questions were 
related to the general experiences of the interviewee and 
his or her environment. The third and fourth addressed 
the impact on their use of psychoactive substances and 
their environment. The final question concerns the influ-
ence of COVID-19 on their treatment and their relation-
ship with the health care worker. 
Each set of questions consisted of three parts based on 
the core of CBT: thoughts, feelings, and behavior. 
2.5. Data collection
The patients were informed about the background and 
aims of the interview. We believed that conducting the 
interviews quickly and submitting a good scientific arti-
cle was important, but taking the ethical approval would 
delay this procedure. Therefore, we have formulated the 
following requirements for participation. In case of re-
fusal to be interviewed, there were no negative conse-
quences for the patients. They were informed that they 
had the right to leave the interview without any negative 
further consequences. There were no incentives for par-
Table 1. Core questions of the semi-structured interview Introduction: The following questions are about the impact of the 
Corona epidemic. We contact you because you are being treated for the use of alcohol or drugs.
Core Questions Secondary questions
1. The Corona 
epidemic affects 
everyone. We would 
like to know how it 
affects you.
A. When you think about Corona, what do you think about this?
B. If you consider Corona, what does the epidemic do to your feelings?
C. If you consider Corona, how does it affect your behavior/actions?
2. What does the Co-
rona epidemic do to 
your environment?
A. How do people around you, your family, friends, or partner speak about the Corona epidemic?
B. How do you feel about the feelings of people around you, your family, friends or partner when it comes to 
the Corona epidemic?
C. Do they behave differently during this time of the Corona epidemic? If so, what do you notice?
3. The following ques-
tions are about what 
the Corona epidemic 
means to you in 
terms of your use of 
substances?
A. How do you think the Corona epidemic will affect your use of substances? What do you think about this?
B. If you think there is a relationship between Corona and your use of substances, what feelings does that 
evoke in you?
C. If you think there is a relationship between Corona and your use of substances, how will this affect your 
behavior?
4. What does the 
Corona epidemic do 
to your environment 
when it comes to 
your use of sub-
stances?
A. How do people around you, your family, friends, or partner speak about the Corona epidemic and your use 
of substances?
B. What do you think people in your environment feel when it comes to the Corona epidemic and your use of 
substances?
C. How do people around you, your family, friends, or partner behave towards you and your use of substances 
in this Corona epidemic?
5. What does the 
Corona epidemic do 
with your treat-
ment of your use 
of substances? Is it 
different?
A. Do you think that Corona has or will have an influence on your treatment?
B. How does it feel to be treated during the Corona epidemic?
C. Do you notice that the Corona epidemic affects your behavior during your treatment?
D. How do health care workers speak about the Corona epidemic and your use of substances?
E. What do you think health care workers feel when it comes to the Corona epidemic and your use of sub-
stances?
F. How do health care workers behave towards you and your use of substances in this Corona epidemic?
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ticipation in the interview. The interview itself was lim-
ited to 25 minutes. All interviews were conducted over 
the phone. The interviewers had a copy of the interview 
(Table 1) at hand and wrote the answers as much they 
could in a column next to the questions. 
2.6. Thematic Analysis:
The written interviews were recorded in a Word docu-
ment and with each new interview the themes emerging 
from the answers were compared with the earlier ones. 
At the 14th and 15th interviews no new themes emerged. 
The next step was to rearrange all the results according 
to the five core questions and then with reference to 
thoughts, feelings, and behavior.
Next, the resulting document was independently analyzed 
by three authors (CDJ, JGDJV, and CV) on main themes 
within the categories of thoughts, feelings, and behavior 
of each of the 5 question sets. Their results were discussed 
in a virtual meeting and disagreements on the grouping of 
themes and subtopics were resolved through consensus.  
3. Results
3.1. Characteristics of the sample
A consecutive series of 15 individuals were asked to 
participate in our research. All accepted to cooperate and 
gave their oral consent. Their sociodemographic charac-
teristics are presented in Table 2. The participants were 
between 27 and 51 years old (mean age = 39 years). 
Most interviewees reported a psychiatric diagnosis in 
combination with a substance-related disorder. Satura-
tion started after the 13th interview. Nine of them were 
directly affected by COVID-19. Two were sick them-
selves, 8 had a close relative affected by the disease, and 
2 of them lost a close relative due to COVID-19 related 
illness. 
3.2. Overview of the perception of the impact of 
COVID-19 
All interviewees reported an impact on them by the 
COVID-19 epidemic. Overall these experiences could 
be divided separately on their thinking, feeling, and be-
havior, but of course they are all narrowly associated. 
The prevalence of negative experiences was far more 
prevalent than neutral or positive experiences. They ap-
preciated being able to share their concerns, albeit in a 
phone call.
3.3. Effects on the interviewees
Most thoughts about the psychological impact were 
expressed as concerns about one’s health and that of oth-
ers: “I think I can get sick just like that, others died”. 
This period of COVID-19 pandemic was perceived as 
dangerous, especially for vulnerable persons such as par-
ents with, for example, a chronic condition. It also cre-
ated confusion: “When I was addicted I isolated myself, 
now I am abstinent and I have to isolate myself!”. Some 
experienced temporary relief: “I think that’s a pleasant 
thought that the bars are closed”. or “All festivals have 
been canceled and that gives me peace of mind”. A few 
who lived in isolation before the COVID-19 epidemic 
reported no positive or negative thoughts.
The reported feelings were almost all negative, ranging 
from angriness, guilt, gloom, fear, panic, restlessness, 
stress, annoying, unsafety, fright, or stress: “Father was 
ill and in the hospital, I was not allowed to go there. That 
was very difficult for me”. An interviewee said he felt 
Table 2. Characteristics of the study sample
Variables Description
Mean age in years (SD; range) 39.2 (8.1; 27-51) 
Gender (male/female) 11/4
Psychiatric diagnosis (n)* Anxiety disorder (3), Affective disorder (3), ADHD (3),PTSD (2), Schizophrenia (2), Autism spectrum disorder (1), Bulimia nervosa (1)








Death of close relatives: 2/13
* Multiple diagnoses per patient 
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‘fairly calm’, a young interviewee said, “I’m not afraid, 
I’m young and energetic”.
The outcome with regard to behavior can be summa-
rized as keeping social distance and includes closing 
yourself off to others, withdrawing, staying at home, 
and avoiding contact. Despite the isolation, not every-
one could find a quiet or relaxing moment, especially if 
one lived in a house with several occupants: “With four 
adolescents at home, it is not easy to find some peace 
for me”. Almost everyone adheres to the hygienic advice 
and the 1.5 m distance rule and finally accepts that it is 
what it is:  “I follow the guidelines, I am more alert and 
tense and finally realize that I have no control and then 
surrender to the situation”. 
3.4. Perceived effect on the environment
According to the experience of the interviewees, close 
relatives react differently, ranging from worried, accept-
ing to casual. There seems to be a difference in reactions 
between younger and older relatives: “Young people are 
laconic, see less danger. The elderly are more anxious, 
more cautious, worrying”. The abstinent patients and 
those in stable recovery mentioned that people in their 
environment seemed to be afraid that they will relapse 
because of the stress raised by COVID-19. Further-
more, they noticed more stress, irritation, and anxiety 
than usual. Some were happy that their family mem-
bers expressed hope and confidence. The interviewees 
noted that people in their environment were isolating or 
hoarding due to the crisis. In general, the lack of physical 
contact was missed by everyone: “There are hardly any 
visitors, and if there is someone I miss a hug”.
3.5. Effects on the use of alcohol and drugs by the 
interviewees
There were certainly negative effects of the epidemic 
on the use of alcohol and drugs. It was more difficult 
to get health care, and especially to get their methadone 
prescription. Barriers to abstain were lower: “As said be-
fore, sitting at home leads to boredom and makes it eas-
ier to grab a beer, you say ‘yes’ to yourself more easily”. 
Some reported no effect on their drug or alcohol use: “I 
have been clean for 1.5 years now. I am strong enough 
not to fall back. Learned a lot in the past year”. Depend-
ing on the stage of recovery, feelings were different. 
Patients who were recently detoxified were concerned 
about relapsing, experienced more stress and craving, 
and felt powerless. Those in stable recovery saw no ef-
fect and realized that the use of alcohol or drugs will not 
help to cope with the negative state caused by the CO-
VID-19 epidemic: “Then I would feel like a weakling 
because I grab every situation to start using again”. In 
relapsing patients, the craving was that strong that they 
went to the shop to buy alcohol or heroin by the dealer 
without thinking of the consequences: “Getting alcohol 
every day is more important for me than the fear of be-
ing contaminated in the store”. Some of the interview-
ees managed to stay abstinent by going for a walk or go 
shopping: “Although a daily visit to a supermarket is not 
recommended, I still do it, precisely not to let my social 
isolation increase even more”. For most, keeping struc-
ture was an important means of preventing a relapse.
3.6. Perceived effect on the environment with re-
gard to the use of alcohol and drugs by the inter-
viewees
Close relatives were usually constructively concerned: 
“They mainly ask if I can keep it up, knowing that I am 
isolated”. Some, however, experienced a more negative 
attitude in their environment: “I always feel that I am 
‘waste’ because I am addicted and my children are in 
youth care and now it is even worse”. Other interview-
ees lived close to other people who used drugs and in 
front of them. They were relaxed and unconcerned and 
behaved laughably: “I am now more often confronted 
with roommates who smoke cannabis; that doesn’t make 
it easier to remain clean!”
3.7. Effect on the treatment of the interviewees
The greatest common denominator in all the inter-
views conducted was the change in the way treatment 
was provided. Much attention was paid to the changed 
rules. There were almost no face-to-face contacts any-
more. Communication to the healthcare provider was 
conducted via telephone and or a video reducing con-
nectedness: “I think the core problem in tackling addic-
tion is being able to reconnect with your environment. 
Now that is hindered by Corona”. Access to health care 
was more difficult. Sometimes therapy appointments 
were delayed or canceled. For one interviewee, this was 
a positive experience: “It works positively for me, it is 
calmer, less intensive, I have more time to think about 
feelings”. Day activities were canceled, leading to a less 
structured daily life for others. Inpatient treatment was 
more disorganized; suddenly there were other health 
workers deployed from other settings and or transfers of 
other patients from wards vacated to create COVID-19 
red zoned units. Significantly during therapy sessions, 
the interviewees were asked little or nothing about what 
the COVID-19 epidemic meant to them.
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The changes in treatment raised negative feelings. On-
line interventions were not well appreciated: “They also 
make me feel more stressed”. Cancellation of treatment 
can result in feelings of anger, rejection, and despair: “If 
you have just abstained from alcohol or drugs and you 
are all alone at home, it is very difficult, especially if you 
no longer have contact with a health care worker”.  
3.8. Perceived effect on the health care workers
Health care workers regularly speak about the rules 
with their patients that have changed by the COVID-19 
epidemic. They were very concerned about what these 
rules exactly meant but they also seemed to experience 
much confusion about their interpretation of these rules: 
“They are agitated and therefore seem to be more con-
cerned with themselves and no longer with the depart-
ment”. Five interviewees explicitly mentioned that their 
health care workers did not speak anything about the 
COVID-19 epidemic with them. 
For most of the interviewees, it was clear that their 
health care workers were also concerned and that they 
expressed feelings of insecurity, powerlessness, and 
stress in a dysfunctional manner with clear implications 
to the therapeutic relationships. 
Lack of appropriate technology that is supported by 
face to face interactions did not help with the above 
thoughts and feelings: “Sometimes the telephone con-
nection drops and I don’t get a call back either”. On one 
occasion, the reaction by the system was draconian: 
“These are the rules, so there is nothing we can do for 
you”. Patients in stable recovery were fully aware of 
their values and renewed skills of self-empowerment 
and self-sufficiency. However, they also missed the calls 
from their former health care worker asking them about 
the impact and how they are dealing with minimizing the 
risk of relapse.  
4. Discussion
After listening to the voice of our patients, it became 
clear that the COVID-19 global epidemic has had a se-
rious impact on the thoughts, feelings, and behavior of 
the interviewees attending mental health and addiction 
care systems. They shared anxieties about their health 
and the health of their relatives. They had frightening 
thoughts associated with a wide range of negative feel-
ings and behavior, such as stress, anger, avoidance, and 
isolation. The psychological responses as expressed in 
thoughts, feelings, and behavior are understandable 
responses to an impending crisis and are not much dif-
ferent from those mentioned by the general population 
(Fardin, 2020; Wang, et al., 2020), the patients infected 
with COVID-19 (Lee et al., 2007) or health care workers 
taking care of COVID-19 patients (Tan et al., 2020). 
The second goal was to find clues in the patients’ an-
swers that could be used to tailor a treatment that uses 
the principles of CBT to the concerns that everyone 
can have during this global pandemic. In this respect, 
it is acknowledged that negative thoughts and fears 
are natural at this time. At the same time, taking a bal-
anced perspective, not assuming the worst, and taking 
the long-term optimistic view can help reduce anxiety 
and stress (World Confederation Of Cognitive And Bet-
havioral Therapies, 2020). When a patient expresses 
such concerns, the health care worker can use general 
principles of  CBT: challenging unhelpful thoughts and 
encouraging the patient to take a balanced perspective, 
easing physical stress and tension (e.g.  relaxation ex-
ercises or meditation and mindfulness), and engaging 
in helpful behavior (e.g.  engage in pleasant events or 
problem-solving). 
The specific effect of the COVID-19 epidemic on the 
use of psychoactive substances was different in the pa-
tients in treatment compared with those who are in stable 
recovery. In the former case, some succeeded in staying 
abstinent, but most were fighting against the craving and 
the temptation to start using again with some relapsing. 
Causality, of course, could not be demonstrated, but it 
is well known that life events such as COVID-19 epi-
demic can lead to relapse (Jessup et al., 2014; McCabe, 
et al., 2016; Pilowsky, Keyes, Geier, Grant, & Hasin, 
2013). Our four patients in a stable recovery managed 
to stay abstinent. They used CBT rules such as asking 
for help, not bending the rules, and practicing self-care 
(Melemis, 2015). The patients in recovery most clearly 
indicated that they had learned not to isolate themselves 
when everything gets tough. They have experienced that 
solidarity and connectedness were essential in sustain-
ing their recovery. The interviewees who were still under 
treatment also noticed that distance has not only become 
physical but that they also felt emotionally isolated and 
sometimes patronized.
Additionally, the COVID-19 pandemic has affected 
relatives which increased the interviewees’ concerns 
about the effect on their family member’s recovery jour-
ney. Family members are an important resource to sup-
port recovery (Andersson et al., 2018). It was encour-
aging that interviewees experienced that close relatives 
were usually constructively concerned. Perceptions of 
reactions of non-relatives in the environment were less 
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positive and referred perhaps to earlier perceptions of 
stigmatization (Yang, Wong, Grivel, & Hasin, 2017) in 
society and or a flare-up of self-stigmatizing thoughts in 
times of crisis (Corrigan & Rao, 2012; Matthews, Dw-
yer, & Snoek, 2017). 
All interviewees reported mostly negative effects of 
the COVID-19 epidemic on their treatment with special 
emphasis on the sudden changes in the rules of engage-
ment during their treatment and the subsequent difficul-
ties arising as practitioners are trying to deal with these 
changes. International policy institutions such as the 
World Health Organisation (WHO) and international 
professional organizations such as the International 
Society of Addiction Medicine (ISAM) have stated in 
the early phase of this crisis that health care institutions 
must adapt and provide the roadmap to reorganize such 
systems (Farhoudian et al., 2020; World Health Organi-
zation, 2020). Our interviewees endorsed this proactive 
approach. However, they also noted that their care pro-
viders are particularly busy adapting to those rules and 
are less focused on their patients. 
It is clear from this small but patient-centered study that 
the participants have all experienced stress in one way or 
another as a result of this pandemic. If that is the case, 
we can more or less speak of a shared trauma which may 
negatively affect the working relationship and reduce the 
effectiveness of the treatment (Cook et al., 2015) offered. 
However, based on the perspective of shared trauma, we 
can also take this opportunity to look at how to approach 
treatment more constructively in this time of crisis than 
is currently the case. 
In case of shared trauma, a health care worker should 
take care of oneself because personal vulnerability is not 
only a backdrop for clinical work but it also changes the 
frame of the work (Saakvitne, 2002). One may experi-
ence more or stronger feelings like fear, anxiety, sadness, 
or depression than what is expected. Normal responses 
like fatigue or absence from clinical practice can influ-
ence professional work and must be recognized and un-
derstood to be dealt with appropriately (American Psy-
chological Association, 2001). Recognizing that a crisis 
can affect a patient, as well as the caregiver, highlights 
the importance of articulating the therapists’ own trau-
ma story and the urgent need to attend to the therapist’s 
self-care before resuming clinical work. It also provides 
opportunities for enhanced therapeutic intimacy and 
caution regarding boundary alterations that may result 
from the therapist’s self-disclosure (Tosone, Nuttman-
Shwartz, & Stephens, 2012). 
We used a convenient sampling method to choose our 
study samples which will implicate strengths as well as 
limitations. First of all, this study is unique because it 
was conducted in situ during the acute phase of the epi-
demic when all the changes in health care identified by 
respondents occurred. All patients participated without 
hesitation and consented via e-mail or WhatsApp. The 
interviewees were under treatment (in- or out-patients) or 
in stable recovery. Many of them had experienced direct 
consequences of COVID-19 because they were infected 
by the virus or had a relative that was ill or even died. We 
realize that we have interviewed a small group so that the 
results cannot simply be generalized. Although we ob-
served saturation after the 13 interviews, bias was to be 
expected because we did not interview homeless people 
and the interviews were conducted before the economic 
consequences of the COVID-19 epidemic. 
Our exploration had thr ee aims. First, we listened to 
the voice of the patients and learned that COVID-19 in-
fluenced their lives in a way that is comparable with we 
all affected by the pandemic. The general impression is 
that because of the many negative thoughts, feelings, and 
behavior, the interviewees in treatment were more vul-
nerable to relapse. Besides the direct effect of the COV-
ID-19 threat, another noticeable physical and emotional 
negative effect is social isolation.
The triad of thoughts, feelings, and behavior forms a 
firm basis for conducting the therapeutic conversation 
from a behavioral therapeutic framework. It starts by 
making a functional analysis and challenging irrational 
thoughts and looking together for more rational thoughts 
that can reduce negative feelings.
The elaboration of the interviewees on the treatment 
and especially on the relationship with their health care 
workers provides promising clues to optimize that rela-
tionship. “We are all in it together!” therapy has changed 
by necessary rules to mitigate COVID-19 spread, and 
patients and health care workers both are troubled by it. 
Just as shared decision making helps to start treatment 
(Joosten, De Weert-Van Oene, Sensky, Van Der Staak, & 
De Jong, 2011), improves the working alliance (Joosten, 
de Weert, Sensky, van der Staak, & de Jong, 2008), the 
adherence (Hell & Nielsen, 2020; Joosten et al., 2008) 
and the efficacy (Joosten, de Jong, de Weert-van Oene, 
Sensky, & van der Staak, 2009), this method could very 
well be used to shape effective and receptive treatment 
interventions during the different challenges faced at dif-
ferent stages of the COVID-19 epidemic. 
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Ethical Considerations
Compliance with ethical guidelines
We believed that conducting the interviews quickly 
and submitting a good scientific article was important, 
but taking the ethical approval would delay this proce-
dure. Therefore, we have formulated the following re-
quirements for participation. The patients were informed 
about the background and aims of the interview. In case 
of refusal to be interviewed, there were no negative con-
sequences for the patients. They were informed that they 
had the right to leave the interview without any nega-
tive further consequences. There were no incentives for 
participation in the interview. The interview itself was 
limited to 25 minutes. All interviews were conducted 
over the phone.
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